Direct evidence for the activation of phospholipase Cγ1 by in vivo treatment with morphine in the mouse periaqueductal gray matter

Brain Research

Volumn 970, Issue 1-2, 2003, Pages 140-148

  Narita, Minoru ^a   Ohnishi, Orie ^a   Narita, Michiko ^a,b   Aoki, Takeshi ^a   Suzuki, Masami ^a   Yajima, Yoshinori ^a   Funahashi, Hisayuki ^b   Shioda, Seiji ^b   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antinociception; Mouse; Opioid; Periaqueductal gray matter; Phospholipase C

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENZYME ANTIBODY; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PHOSPHOLIPASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; BRAIN CELL; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME SUBUNIT; GENE DELETION; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037466394     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02301-1     Document Type: Article

References (20)

1. Bae Y.S., Cantley L.G., Chen C.S., Kim S.R., Kwon K.S., Rhee S.G. Activation of phospholipase C-γ by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 272:1998;4465-4469.
2. Basbaum A.I., Fields H.L. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat, further studies on the anatomy of pain modulation. J. Comp. Neurol. 187:1979;513-532.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Childers S.R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991;1991-2003.
5. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., Schlessinger J. Activation of phospholipase Cγ by PI3-kinase-induced PH domain-membrane targeting. EMBO J. 17:1998;414-422.
6. Haley M.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
7. oα in smooth muscle. Mol. Pharmacol. 50:1996;870-877.
8. Narita M., Mizoguchi H., Narita M., Dun N.J., Hwang B.H., Endoh T., Suzuki T., Nagase H., Suzuki T., Tseng L.F. G-protein activation by endomorphins in the mouse periaqueductal gray matter. J. Biomed. Sci. 7:2000;221-225.
9. Narita M., Ohsawa M., Mizoguchi H., Aoki T., Suzuki T., Tseng L.F. Role of phosphatidylinositol-specific phospholipase C pathway in δ-opioid receptor-mediated antinociception in the mouse spinal cord. Neuroscience. 99:2000;327-331.
10. Narita M., Funada M., Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89:2001;1-15.
11. Narita M., Ohnishi O., Nemoto M., Yajima Y., Suzuki T. Implications of phosphoinositide 3-kinase in the μ- and δ-opioid receptor-mediated supraspinal antinociception in the mouse. Neuroscience. 113:2002;647-652.
12. Noh D.Y., Shin S.H., Rhee S.G. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim. Biophys. Acta. 1242:1995;99-113.
13. Ji Q.-S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., Carpenter G. Essential role of the tyrosine kinase substrate phospholipase C-γ1 in mammalian growth and development. Proc. Natl. Acad. Sci. USA. 94:1997;2999-3003.
14. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80:2000;1291-1335.
15. Reichling D.B., Kwait G.C., Basbaum A.I. Anatomy and pharmacology of the periaqueductal gray contribution to antinociceptive controls. Prog. Brain Res. 77:1988;31-46.
16. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:1997;15045-15048.
17. Sekiya F., Bae Y.S., Rhee S.G. Regulation of phospholipase C isozymes: activation of phospholipase C-γ in the absence of tyrosine-phosphorylation. Chem. Phys. Lipids. 98:1999;3-11.
18. Standifer K.M., Pasternak G.W. G proteins and opioid receptor-mediated signalling. Cell Signal. 9:1997;237-248.
19. Vanhaesebroeck B., Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253:1999;239-254.
20. Williams F.G., Mullet M.A., Beitz A.J. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat, a microdialysis study of antinociceptive circuits. Brain Res. 690:1995;207-216.